热门资讯> 正文

Alcon将以每股28美元的价格收购STAAR Surgical，通过EVO ICL技术扩大视力矫正产品组合

2025-08-05 13:28

STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes
Acquisition of STAAR is complementary to Alcon's laser vision correction business and is expected to be accretive in year two
Alcon to purchase all outstanding shares of STAAR for $28 per share in cash, valuing STAAR at approximately $1.5 billion in equity value

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。